Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 1

1(16.7%)

6Total

N/A(5)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04780191Not ApplicableCompleted

Investigation of Treatment Using the MyoRegulator® Device in Patients With Spasticity in the Lower Limb Due to Stroke

Role: collaborator

NCT07467850Not ApplicableCompleted

Dual Stimulation for Spinal Cord Injury

Role: collaborator

NCT06649955Not ApplicableRecruiting

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Role: lead

NCT06165172Not ApplicableCompleted

Early Feasibility Study of the MyoRegulator® for Treatment of ALS

Role: lead

NCT04742257Not ApplicableTerminated

Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity

Role: lead

NCT03080454Phase 1Completed

The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke

Role: collaborator

All 6 trials loaded